Per-cutaneous Intervention Based Paclitaxel and Sirolimus-Eluting Versus Bare Stents for the Treatment of de Novo Coronary Lesions (PAINT)

NCT00752362 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

280

Enrollment

INDUSTRY

Sponsor class

Conditions

Coronary Restenosis

Interventions

DEVICE: Milennium Matrix® (Control)
DEVICE: Infinnium®
DEVICE: Supralimus®

Sponsor

Sahajanand Medical Technologies Limited

Collaborators

[object Object]